209.7K XNAS Volume
XNAS 02 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Craig Tendler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 151,883 | 151,883 | - | - | Options (Right to Buy) | |
| James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 59,590 | 59,590 | - | - | Options (Right to Buy) | |
| Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 51,275 | 51,275 | - | - | Options (Right to Buy) | |
| Alan List | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 51,275 | 51,275 | - | - | Options (Right to Buy) | |
| James A. Bianco | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 1,065,990 | 1,065,990 | - | - | Options (Right to Buy) | |
| Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2024 | 489,848 | 489,848 | - | - | Options (Right to Buy) | |
| James A. Bianco | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 2,323,307 | 2,323,307 | - | 0 | Common Stock | |
| James A. Bianco | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 357,800 | 357,800 | - | - | Options (Right to Buy) | |
| James A. Bianco | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 71,560 | 71,560 | - | - | Options (Right to Buy) | |
| James A. Bianco | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 191,280 | 191,280 | - | - | Options (Right to Buy) | |
| James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 13,553 | 13,553 | - | - | Options (Right to Buy) | |
| James S.J. Manuso | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 13,553 | 13,553 | - | - | Options (Right to Buy) | |
| Alan List | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 13,553 | 13,553 | - | - | Options (Right to Buy) | |
| Alan List | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 13,553 | 13,553 | - | - | Options (Right to Buy) | |
| Dennis Yamashita | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 196,790 | 196,790 | - | - | Options (Right to Buy) | |
| Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 66,658 | 66,658 | - | - | Options (Right to Buy) | |
| Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 15,744 | 15,744 | - | - | Options (Right to Buy) | |
| Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 232,570 | 232,570 | - | - | Options (Right to Buy) | |
| Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 68,438 | 68,438 | - | - | Options (Right to Buy) | |
| Daniel Dearborn | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2024 | 33,991 | 33,991 | - | - | Options (Right to Buy) | |
| Robert E. Hoffman | Director, President, CEO, and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 59,800 | 68,902 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | |
| Dennis Brown | Chief Scientific Officer | 05 Jan 2023 | 363 | 5,302 (0%) | 0% | 0 | Common Stock, par value $0.001 per share | ||
| Dennis Brown | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 240,087 | 246,905 (2%) | 2% | 0 | Common Stock | |
| Dennis Brown | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 720,260 | 720,260 | - | - | Option (right to buy) | |
| Robert E. Hoffman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 1,200,634 | 1,200,634 | - | - | Option (right to buy) | |
| Robert E. Hoffman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 400,145 | 455,145 (3%) | 3% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 240,087 | 277,273 (2%) | 2% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2022 | 720,260 | 720,260 | - | - | Option (right to buy) | |
| Tamara A. Seymour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| Robert J. Toth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| Laura Johnson Douglass | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jul 2022 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| Robert E. Hoffman | Director, President and CEO | Purchase of securities on an exchange or from another person at price $ 0.47 per share. | 15 Feb 2022 | 55,000 | 55,000 (0%) | 0% | 0.5 | 25,795 | Common Stock |
| Scott Praill | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.68 per share. | 08 Dec 2021 | 28,700 | 37,186 (0%) | 0% | 0.7 | 19,430 | Common Stock |
| Saiid Zarrabian | Director, Head of Strategic Partnerships | Purchase of securities on an exchange or from another person at price $ 0.64 per share. | 06 Dec 2021 | 38,109 | 55,500 (0%) | 0% | 0.6 | 24,298 | Common Stock |
| Saiid Zarrabian | Director, Head of Strategic Partnerships | Purchase of securities on an exchange or from another person at price $ 0.59 per share. | 06 Dec 2021 | 11,891 | 17,391 (0%) | 0% | 0.6 | 7,018 | Common Stock |
| Laura Johnson Douglass | Director | Purchase of securities on an exchange or from another person at price $ 0.74 per share. | 22 Nov 2021 | 3,000 | 3,000 (0%) | 0% | 0.7 | 2,227 | Common Stock |
| Robert E. Hoffman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2021 | 3,519,170 | 3,519,170 | - | - | Options (Right to Buy) | |
| Tamara A. Seymour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2021 | 35,000 | 35,000 | - | - | Options (Right to Buy) | |
| Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2021 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| Keith Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2021 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| Robert J. Toth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2021 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| Laura Johnson Douglass | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2021 | 100,000 | 100,000 | - | - | Options (Right to Buy) | |
| Dennis Brown | Chief Scientific Officer | 29 Apr 2021 | 3,000 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 29 Apr 2021 | 6 | 6,068 (0%) | 0% | 0 | Common Stock | |
| Dennis Brown | Chief Scientific Officer | 29 Apr 2021 | 750 | 6,818 (0%) | 0% | - | Common Stock | ||
| Tamara A. Seymour | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2021 | 75,000 | 75,000 | - | - | Options (Right to Grant) | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 29 Apr 2021 | 8 | 7,548 (0%) | 0% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | 29 Apr 2021 | 3,750 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Scott Praill | Chief Financial Officer | 29 Apr 2021 | 938 | 8,486 (0%) | 0% | - | Common Stock | ||
| Robert J. Toth | Director | 29 Apr 2021 | 1,300 | 0 | - | - | Series B Convertible Preferred Stock | ||
| Robert J. Toth | Director | 29 Apr 2021 | 325 | 1,566 (0%) | 0% | - | Common Stock | ||
| Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 29 Apr 2021 | 3 | 1,241 (0%) | 0% | 0 | Common Stock | |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 31 Mar 2021 | 17 | 6,062 (0%) | 0% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 31 Mar 2021 | 22 | 7,540 (0%) | 0% | 0 | Common Stock | |
| Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 31 Mar 2021 | 8 | 1,238 (0%) | 0% | 0 | Common Stock | |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 30 Sep 2020 | 17 | 6,028 (0%) | 0% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 30 Sep 2020 | 22 | 7,496 (0%) | 0% | 0 | Common Stock | |
| Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 30 Sep 2020 | 8 | 1,222 (0%) | 0% | 0 | Common Stock | |
| Dennis Brown | Chief Scientifc Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Sep 2020 | 60,000 | 60,000 | - | - | Options (Right to Buy) | |
| Dennis Brown | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 87,437 | 87,437 | - | - | Options (Right to Buy) | |
| Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 120,000 | 120,000 | - | - | Options (Right to Buy) | |
| Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 606,557 | 606,557 | - | - | Options (Right to Buy) | |
| Saiid Zarrabian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 2,715,004 | 2,715,004 | - | - | Options (Right to Buy) | |
| Keith Murphy | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 120,000 | 120,000 | - | - | Options (Right to Buy) | |
| Robert J. Toth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 120,000 | 120,000 | - | - | Options (Right to Buy) | |
| Laura Johnson Douglass | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 120,000 | 120,000 | - | - | Options (Right to Buy) | |
| John Liatos | Director, SVP, Business Development | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Sep 2020 | 506,647 | 506,647 | - | - | Options (Right to Buy) | |
| Keith Murphy | Director | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Aug 2020 | 181,010 | 181,010 (1%) | 1% | - | Common Stock | |
| John Liatos | Director, SVP, Business Development | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 19 Aug 2020 | 196,750 | 196,750 (1%) | 1% | - | Common Stock | |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 26 Jun 2020 | 17 | 6,011 (0%) | 0% | 0 | Common Stock | |
| Dennis Brown | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 250,000 | 250,000 | - | - | Options (Right to Buy) | |
| Dennis Brown | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 52,756 | 100,000 | - | - | Options (Right to Buy) | |
| Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 39,567 | 75,000 | - | - | Options (Right to Buy) | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 26 Jun 2020 | 22 | 7,474 (0%) | 0% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 57,170 | 108,366 | - | - | Option (Right to Buy) | |
| John Bell | Director | Other type of transaction at price $ 0.00 per share. | 26 Jun 2020 | 29 | 9,817 (0%) | 0% | 0 | Common Stock | |
| John Bell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 39,567 | 75,000 | - | - | Options (Right to Buy) | |
| Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 26 Jun 2020 | 8 | 1,214 (0%) | 0% | 0 | Common Stock | |
| Robert J. Toth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 39,567 | 75,000 | - | - | Option (Right to Buy) | |
| Lynda Cranston | Director | Other type of transaction at price $ 0.00 per share. | 26 Jun 2020 | 8 | 332 (0%) | 0% | 0 | Common Stock | |
| Lynda Cranston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 39,567 | 75,000 | - | - | Option (Right to Buy) | |
| Napoleone Ferrara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2020 | 39,567 | 75,000 | - | - | Options (Right to Buy) | |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 31 Mar 2020 | 17 | 5,994 (0%) | 0% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 31 Mar 2020 | 22 | 7,452 (0%) | 0% | 0 | Common Stock | |
| John Bell | Director | Other type of transaction at price $ 0.00 per share. | 31 Mar 2020 | 29 | 9,788 (0%) | 0% | 0 | Common Stock | |
| Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 31 Mar 2020 | 8 | 1,206 (0%) | 0% | 0 | Common Stock | |
| Lynda Cranston | Director | Other type of transaction at price $ 0.00 per share. | 31 Mar 2020 | 8 | 324 (0%) | 0% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2019 | 22 | 7,430 (0%) | 0% | 0 | Common Stock | |
| John Bell | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2019 | 29 | 9,759 (0%) | 0% | 0 | Common Stock | |
| Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2019 | 8 | 1,198 (0%) | 0% | 0 | Common Stock | |
| Lynda Cranston | Director | Other type of transaction at price $ 0.00 per share. | 31 Dec 2019 | 8 | 316 (0%) | 0% | 0 | Common Stock | |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 27 Dec 2019 | 17 | 5,977 (0%) | 0% | 0 | Common Stock | |
| Dennis Brown | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 27 Dec 2019 | 7,500 | 5,960 (0%) | 0% | 0 | Common Stock | |
| Dennis Brown | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Nov 2019 | 250,000 | 250,000 | - | - | Options (Right to Buy) | |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 30 Sep 2019 | 17 | 13,460 (0%) | 0% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 30 Sep 2019 | 22 | 7,408 (0%) | 0% | 0 | Common Stock | |
| John Bell | Director | Other type of transaction at price $ 0.00 per share. | 30 Sep 2019 | 29 | 9,730 (0%) | 0% | 0 | Common Stock | |
| Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 30 Sep 2019 | 8 | 1,190 (0%) | 0% | 0 | Common Stock | |
| Lynda Cranston | Director | Other type of transaction at price $ 0.00 per share. | 30 Sep 2019 | 8 | 308 (0%) | 0% | 0 | Common Stock | |
| John Bell | Director | Purchase of securities on an exchange or from another person at price $ 0.68 per share. | 13 Sep 2019 | 35,000 | 35,000 (0%) | 0% | 0.7 | 23,744 | Common Stock |
| Dennis Brown | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 47,244 | 47,244 | - | - | Options (Right to Buy) | |
| Dennis Brown | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 52,756 | 52,756 | - | - | Options (Right to Buy) | |
| Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 35,433 | 35,433 | - | - | Options (Right to Buy) | |
| Robert E. Hoffman | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 39,567 | 39,567 | - | - | Options (Right to Buy) | |
| Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 57,170 | 57,170 | - | - | Options (Right to Buy) | |
| Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 51,196 | 51,196 | - | - | Options (Right to Buy) | |
| Saiid Zarrabian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 241,438 | 457,650 | - | - | Options (Right to Buy) | |
| Saiid Zarrabian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 216,212 | 216,212 | - | - | Options (Right to Buy) | |
| Saiid Zarrabian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 241,438 | 241,438 | - | - | Options (Right to Buy) | |
| John Bell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 39,567 | 39,567 | - | - | Options (Right to Buy) | |
| John Bell | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 35,433 | 35,433 | - | - | Options (Right to Buy) | |
| Robert J. Toth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 35,433 | 35,433 | - | - | Options (Right to Buy) | |
| Robert J. Toth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 39,567 | 39,567 | - | - | Options (Right to Buy) | |
| Lynda Cranston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 39,567 | 39,567 | - | - | Options (Right to Buy) | |
| Lynda Cranston | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 35,433 | 35,433 | - | - | Options (Right to Buy) | |
| Napoleone Ferrara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 35,433 | 35,433 | - | - | Options (Right to Buy) | |
| Napoleone Ferrara | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Sep 2019 | 39,567 | 39,567 | - | - | Options (Right to Buy) | |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 28 Jun 2019 | 17 | 13,443 (0%) | 0% | 0 | Common Stock | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 28 Jun 2019 | 22 | 7,386 (0%) | 0% | 0 | Common Stock | |
| John Bell | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2019 | 29 | 9,701 (0%) | 0% | 0 | Common Stock | |
| Robert J. Toth | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2019 | 8 | 1,182 (0%) | 0% | 0 | Common Stock | |
| Lynda Cranston | Director | Other type of transaction at price $ 0.00 per share. | 28 Jun 2019 | 8 | 300 (0%) | 0% | 0 | Common Stock | |
| Robert E. Hoffman | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2019 | 200,000 | 0 | - | - | Performance Stock Units | |
| Saiid Zarrabian | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2019 | 200,000 | 0 | - | - | Performance Stock Units | |
| John Bell | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2019 | 200,000 | 0 | - | - | Performance Stock Units | |
| Robert J. Toth | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2019 | 200,000 | 0 | - | - | Performance Stock Units | |
| Lynda Cranston | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2019 | 200,000 | 0 | - | - | Performance Stock Units | |
| Napoleone Ferrara | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 30 Apr 2019 | 200,000 | 0 | - | - | Performance Stock Units | |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.49 per share. | 29 Mar 2019 | 169 | 134,260 (1%) | 0% | 0.5 | 83 | Common Stock |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.49 per share. | 29 Mar 2019 | 211 | 73,632 (0%) | 0% | 0.5 | 103 | Common Stock |
| John Bell | Director | Other type of transaction at price $ 0.49 per share. | 29 Mar 2019 | 282 | 96,711 (0%) | 0% | 0.5 | 138 | Common Stock |
| Robert J. Toth | Director | Other type of transaction at price $ 0.49 per share. | 29 Mar 2019 | 74 | 11,739 (0%) | 0% | 0.5 | 36 | Common Stock |
| Lynda Cranston | Director | Other type of transaction at price $ 0.49 per share. | 29 Mar 2019 | 71 | 2,912 (0%) | 0% | 0.5 | 35 | Common Stock |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.34 per share. | 31 Dec 2018 | 211 | 73,421 (0%) | 0% | 0.3 | 72 | Common Stock |
| John Bell | None | Other type of transaction at price $ 0.34 per share. | 31 Dec 2018 | 282 | 96,429 (0%) | 0% | 0.3 | 96 | Common Stock |
| Robert J. Toth | None | Other type of transaction at price $ 0.34 per share. | 31 Dec 2018 | 74 | 11,665 (0%) | 0% | 0.3 | 25 | Common Stock |
| Lynda Cranston | None | Other type of transaction at price $ 0.34 per share. | 31 Dec 2018 | 71 | 2,841 (0%) | 0% | 0.3 | 24 | Common Stock |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 0.34 per share. | 21 Dec 2018 | 169 | 134,091 (0%) | 0% | 0.3 | 58 | Common Stock |
| Dennis Brown | Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Dec 2018 | 85,000 | 133,922 (0%) | 0% | 0 | Common Stock | |
| Robert E. Hoffman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2018 | 40,000 | 40,000 | - | - | Options (Right to Buy) | |
| Scott Praill | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2018 | 100,000 | 100,000 | - | - | Employee Stock Option (Right to Buy) | |
| John Bell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2018 | 40,000 | 40,000 | - | - | Options (Right to Buy) | |
| Robert J. Toth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2018 | 40,000 | 40,000 | - | - | Options (Right to Buy) | |
| Lynda Cranston | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2018 | 40,000 | 40,000 | - | - | Options (Right to Buy) | |
| Napoleone Ferrara | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2018 | 40,000 | 40,000 | - | - | Options (Right to Buy) | |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 3.20 per share. | 28 Sep 2018 | 169 | 218,922 (0%) | 0% | 3.2 | 541 | Common Stock |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 3.20 per share. | 28 Sep 2018 | 211 | 73,210 (0%) | 0% | 3.2 | 675 | Common Stock |
| John Bell | None | Other type of transaction at price $ 3.20 per share. | 28 Sep 2018 | 282 | 96,147 (0%) | 0% | 3.2 | 902 | Common Stock |
| Robert J. Toth | None | Other type of transaction at price $ 3.20 per share. | 28 Sep 2018 | 74 | 11,591 (0%) | 0% | 3.2 | 237 | Common Stock |
| Lynda Cranston | None | Other type of transaction at price $ 3.20 per share. | 28 Sep 2018 | 71 | 2,770 (0%) | 0% | 3.2 | 227 | Common Stock |
| Dennis Brown | Chief Scientific Officer | Other type of transaction at price $ 3.20 per share. | 29 Jun 2018 | 169 | 218,753 (0%) | 0% | 3.2 | 541 | Common Stock |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 3.20 per share. | 29 Jun 2018 | 211 | 72,999 (0%) | 0% | 3.2 | 675 | Common Stock |
| John Bell | None | Other type of transaction at price $ 3.20 per share. | 29 Jun 2018 | 282 | 95,865 (0%) | 0% | 3.2 | 902 | Common Stock |
| Robert J. Toth | None | Other type of transaction at price $ 3.20 per share. | 29 Jun 2018 | 74 | 11,517 (0%) | 0% | 3.2 | 237 | Common Stock |
| Lynda Cranston | None | Other type of transaction at price $ 3.20 per share. | 29 Jun 2018 | 71 | 2,699 (0%) | 0% | 3.2 | 227 | Common Stock |
| Napoleone Ferrara | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 200,000 | 200,000 | - | - | Performance Stock Units | |
| Napoleone Ferrara | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2018 | 54,514 | 54,514 | - | - | Options (Right to Buy) | |
| Saiid Zarrabian | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2018 | 836,465 | 836,465 | - | - | Employee Stock Option (right to buy) | |
| Robert E. Hoffman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2018 | 200,000 | 200,000 | - | - | Performance Stock Units | |
| Robert E. Hoffman | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Apr 2018 | 36,000 | 36,000 | - | - | Options (Right to Buy) | |
| Dennis Brown | Director, Chief Scientific Officer | Other type of transaction at price $ 3.20 per share. | 30 Mar 2018 | 169 | 218,584 (0%) | 0% | 3.2 | 541 | Common Stock |
| Erich Mohr | None | Other type of transaction at price $ 3.20 per share. | 30 Mar 2018 | 528 | 8,222 (0%) | 0% | 3.2 | 1,690 | Common Stock |
| Jeffrey A. Bacha | None | Other type of transaction at price $ 3.20 per share. | 30 Mar 2018 | 176 | 64,049 (0%) | 0% | 3.2 | 563 | Common Stock |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 3.20 per share. | 30 Mar 2018 | 211 | 72,788 (0%) | 0% | 3.2 | 675 | Common Stock |
| John Bell | None | Other type of transaction at price $ 3.20 per share. | 30 Mar 2018 | 282 | 95,583 (0%) | 0% | 3.2 | 902 | Common Stock |
| Robert J. Toth | None | Other type of transaction at price $ 3.20 per share. | 30 Mar 2018 | 74 | 11,443 (0%) | 0% | 3.2 | 237 | Common Stock |
| Lynda Cranston | None | Other type of transaction at price $ 3.20 per share. | 30 Mar 2018 | 71 | 2,628 (0%) | 0% | 3.2 | 227 | Common Stock |
| Erich Mohr | None | Other type of transaction at price $ 3.20 per share. | 31 Dec 2017 | 528 | 7,694 (0%) | 0% | 3.2 | 1,690 | Common Stock |
| Scott Praill | Chief Financial Officer | 31 Dec 2017 | 25,000 | 72,577 (0%) | 0% | 0 | Common Stock | ||
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 3.20 per share. | 31 Dec 2017 | 211 | 47,577 (0%) | 0% | 3.2 | 675 | Common Stock |
| Scott Praill | Chief Financial Officer | 31 Dec 2017 | 25,000 | 0 | - | - | Exchangeable Shares | ||
| John Bell | None | Other type of transaction at price $ 3.20 per share. | 31 Dec 2017 | 282 | 95,301 (0%) | 0% | 3.2 | 902 | Common Stock |
| Robert J. Toth | None | Other type of transaction at price $ 3.20 per share. | 31 Dec 2017 | 74 | 11,369 (0%) | 0% | 3.2 | 237 | Common Stock |
| Lynda Cranston | None | Other type of transaction at price $ 3.20 per share. | 31 Dec 2017 | 71 | 2,557 (0%) | 0% | 3.2 | 227 | Common Stock |
| Jeffrey A. Bacha | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Dec 2017 | 37,500 | 0 | - | - | Options (Right to Buy) | |
| Jeffrey A. Bacha | None | Other type of transaction at price $ 3.20 per share. | 22 Dec 2017 | 176 | 63,873 (0%) | 0% | 3.2 | 563 | Common Stock |
| Jeffrey A. Bacha | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2017 | 87,500 | 87,500 | - | - | Options (Right to Buy) | |
| Jeffrey A. Bacha | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Dec 2017 | 87,500 | 0 | - | - | Options (Right to Buy) | |
| Jeffrey A. Bacha | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2017 | 37,500 | 37,500 | - | - | Options (Right to Buy) | |
| Jeffrey A. Bacha | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2017 | 93,600 | 93,600 | - | - | Options (Right to Buy) | |
| Jeffrey A. Bacha | None | Sale or transfer of securities back to the company at price $ 0.00 per share. | 22 Dec 2017 | 93,600 | 0 | - | - | Options (Right to Buy) | |
| Dennis Brown | Director, Chief Scientific Officer | Other type of transaction at price $ 3.20 per share. | 13 Dec 2017 | 169 | 218,415 (0%) | 0% | 3.2 | 541 | Common Stock |
| Dennis Brown | Director, Chief Scientific Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 13 Dec 2017 | 129,600 | 218,246 (1%) | 0% | 0 | Common Stock | |
| John Bell | None | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 15 Nov 2017 | 1,871 | 76,890 (0%) | 0% | 0.8 | 1,516 | Common Stock |
| John Bell | None | Purchase of securities on an exchange or from another person at price $ 0.81 per share. | 15 Nov 2017 | 18,129 | 95,019 (0%) | 0% | 0.8 | 14,684 | Common Stock |
| Saiid Zarrabian | Director, Interim CEO | Purchase of securities on an exchange or from another person at price $ 0.84 per share. | 14 Nov 2017 | 5,900 | 5,900 (0%) | 0% | 0.8 | 4,956 | Common Stock |
| Saiid Zarrabian | Director, Interim CEO | Purchase of securities on an exchange or from another person at price $ 0.82 per share. | 14 Nov 2017 | 55,000 | 55,000 (0%) | 0% | 0.8 | 45,100 | Common Stock |
| Saiid Zarrabian | Director, Interim CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Nov 2017 | 120,000 | 120,000 | - | - | Options (Right to Buy) | |
| Jeffrey A. Bacha | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.87 per share. | 06 Oct 2017 | 7,550 | 61,247 (0%) | 0% | 0.9 | 6,569 | Common Stock |
| Jeffrey A. Bacha | Director, CEO | Purchase of securities on an exchange or from another person at price $ 0.88 per share. | 06 Oct 2017 | 2,450 | 63,697 (0%) | 0% | 0.9 | 2,156 | Common Stock |
| Scott Praill | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 05 Oct 2017 | 17,500 | 47,366 (0%) | 0% | 0.9 | 14,910 | Common Stock |
| Dennis Brown | Director, Chief Scientific Officer | Other type of transaction at price $ 3.20 per share. | 29 Sep 2017 | 169 | 885,346 (4%) | 0% | 3.2 | 541 | Common Stock |
| Erich Mohr | None | Other type of transaction at price $ 3.20 per share. | 29 Sep 2017 | 528 | 7,166 (0%) | 0% | 3.2 | 1,690 | Common Stock |
| Jeffrey A. Bacha | Director, CEO | Other type of transaction at price $ 3.20 per share. | 29 Sep 2017 | 176 | 53,697 (0%) | 0% | 3.2 | 563 | Common Stock |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 3.20 per share. | 29 Sep 2017 | 211 | 29,866 (0%) | 0% | 3.2 | 675 | Common Stock |
| John Bell | None | Other type of transaction at price $ 3.20 per share. | 29 Sep 2017 | 282 | 75,019 (0%) | 0% | 3.2 | 902 | Common Stock |
| Robert J. Toth | None | Other type of transaction at price $ 3.20 per share. | 29 Sep 2017 | 74 | 11,295 (0%) | 0% | 3.2 | 237 | Common Stock |
| Lynda Cranston | None | Other type of transaction at price $ 3.20 per share. | 29 Sep 2017 | 71 | 2,486 (0%) | 0% | 3.2 | 227 | Common Stock |
| John Bell | None | 01 Aug 2017 | 25,000 | 0 | - | - | Exchangeable Shares | ||
| John Bell | None | 01 Aug 2017 | 25,000 | 74,737 (0%) | 0% | 0 | Common Stock | ||
| Erich Mohr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 200,000 | 200,000 | - | - | Performance Stock Units | |
| Erich Mohr | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 36,000 | 36,000 | - | - | Options (Right to Buy) | |
| Saiid Zarrabian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 36,000 | 36,000 | - | - | Options (Right to Buy) | |
| Saiid Zarrabian | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 200,000 | 200,000 | - | - | Performance Stock Units | |
| John Bell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 200,000 | 200,000 | - | - | Performance Stock Units | |
| John Bell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 36,000 | 36,000 | - | - | Options (Right to Buy) | |
| Robert J. Toth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 36,000 | 36,000 | - | - | Options (Right to Buy) | |
| Robert J. Toth | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 200,000 | 200,000 | - | - | Performance Stock Units | |
| Lynda Cranston | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 200,000 | 200,000 | - | - | Performance Stock Units | |
| Lynda Cranston | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jul 2017 | 36,000 | 36,000 | - | - | Options (Right to Buy) | |
| Dennis Brown | Director, Chief Scientific Officer | Other type of transaction at price $ 3.20 per share. | 30 Jun 2017 | 169 | 885,177 (6%) | 0% | 3.2 | 541 | Common Stock |
| Erich Mohr | None | Other type of transaction at price $ 3.20 per share. | 30 Jun 2017 | 528 | 6,638 (0%) | 0% | 3.2 | 1,690 | Common Stock |
| Jeffrey A. Bacha | Director, CEO | Other type of transaction at price $ 3.20 per share. | 30 Jun 2017 | 176 | 53,521 (0%) | 0% | 3.2 | 563 | Common Stock |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 3.20 per share. | 30 Jun 2017 | 211 | 29,655 (0%) | 0% | 3.2 | 675 | Common Stock |
| John Bell | None | Other type of transaction at price $ 3.20 per share. | 30 Jun 2017 | 282 | 49,737 (0%) | 0% | 3.2 | 902 | Common Stock |
| Robert J. Toth | None | Other type of transaction at price $ 3.20 per share. | 30 Jun 2017 | 74 | 11,221 (0%) | 0% | 3.2 | 237 | Common Stock |
| Lynda Cranston | None | Other type of transaction at price $ 3.20 per share. | 30 Jun 2017 | 71 | 2,415 (0%) | 0% | 3.2 | 227 | Common Stock |
| Erich Mohr | None | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 26 Jun 2017 | 4,167 | 6,110 (0%) | 0% | 3.6 | 15,001 | Common Stock |
| Jeffrey A. Bacha | Director, CEO | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 26 Jun 2017 | 6,700 | 53,345 (0%) | 0% | 3.6 | 24,120 | Common Stock |
| Scott Praill | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 26 Jun 2017 | 4,167 | 29,444 (0%) | 0% | 3.6 | 15,001 | Common Stock |
| John Bell | None | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 26 Jun 2017 | 4,167 | 49,455 (0%) | 0% | 3.6 | 15,001 | Common Stock |
| Lynda Cranston | None | Purchase of securities on an exchange or from another person at price $ 3.60 per share. | 26 Jun 2017 | 2,083 | 2,344 (0%) | 0% | 3.6 | 7,499 | Common Stock |
| Jeffrey A. Bacha | Director, CEO | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 06 Jun 2017 | 5,000 | 46,645 (0%) | 0% | 2.1 | 10,600 | Common Stock |
| Scott Praill | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 2.10 per share. | 06 Jun 2017 | 9,500 | 25,277 (0%) | 0% | 2.1 | 19,950 | Common Stock |
| John Bell | None | Purchase of securities on an exchange or from another person at price $ 2.12 per share. | 06 Jun 2017 | 10,000 | 45,288 (0%) | 0% | 2.1 | 21,200 | Common Stock |
| Jeffrey A. Bacha | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 2.20 per share. | 05 May 2017 | 2,500 | 41,645 (0%) | 0% | 2.2 | 5,500 | Common Stock |
| Dennis Brown | Director, Chief Scientific Officer | Other type of transaction at price $ 3.20 per share. | 31 Mar 2017 | 169 | 885,008 (7%) | 0% | 3.2 | 541 | Common Stock |
| Erich Mohr | None | Other type of transaction at price $ 3.20 per share. | 31 Mar 2017 | 528 | 1,943 (0%) | 0% | 3.2 | 1,690 | Common Stock |
| Jeffrey A. Bacha | Director, Chief Executive Officer | Other type of transaction at price $ 3.20 per share. | 31 Mar 2017 | 176 | 39,145 (0%) | 0% | 3.2 | 563 | Common Stock |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 3.20 per share. | 31 Mar 2017 | 211 | 15,777 (0%) | 0% | 3.2 | 675 | Common Stock |
| John Bell | None | Other type of transaction at price $ 3.20 per share. | 31 Mar 2017 | 282 | 35,288 (0%) | 0% | 3.2 | 902 | Common Stock |
| Robert J. Toth | None | Other type of transaction at price $ 3.20 per share. | 31 Mar 2017 | 74 | 11,147 (0%) | 0% | 3.2 | 237 | Common Stock |
| Lynda Cranston | None | Other type of transaction at price $ 3.20 per share. | 31 Mar 2017 | 71 | 261 (0%) | 0% | 3.2 | 227 | Common Stock |
| Dennis Brown | Director, Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2017 | 93,600 | 93,600 | - | - | Options (Right to Buy) | |
| Jeffrey A. Bacha | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2017 | 93,600 | 93,600 | - | - | Options (Right to Buy) | |
| Scott Praill | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2017 | 37,400 | 37,400 | - | - | Options (Right to Buy) | |
| Dennis Brown | Director, Chief Scientific Officer | 31 Jan 2017 | 125,000 | 0 | - | - | Warrants (Right to buy) | ||
| Dennis Brown | Director, Chief Scientific Officer | 31 Jan 2017 | 125,000 | 884,839 (8%) | 1% | 1.5 | 192,075 | Common Stock | |
| Dennis Brown | Director, Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2016 | 169 | 759,839 | - | - | Common Stock | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2016 | 211 | 15,566 | - | - | Common Stock | |
| Erich Mohr | None | Other type of transaction at price $ 0.00 per share. | 31 Dec 2016 | 528 | 1,415 | - | - | Common Stock | |
| Jeffrey A. Bacha | Director, CEO | Other type of transaction at price $ 0.00 per share. | 31 Dec 2016 | 176 | 34,969 | - | - | Common Stock | |
| John Bell | None | Other type of transaction at price $ 0.00 per share. | 31 Dec 2016 | 282 | 35,006 | - | - | Common Stock | |
| Robert J. Toth | None | Other type of transaction at price $ 0.00 per share. | 31 Dec 2016 | 74 | 11,073 | - | - | Common Stock | |
| Lynda Cranston | None | Other type of transaction at price $ 0.00 per share. | 31 Dec 2016 | 71 | 190 | - | - | Common Stock | |
| Dennis Brown | Director, Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2016 | 169 | 759,670 | - | - | Common Stock | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 03 Oct 2016 | 211 | 15,355 | - | - | Common Stock | |
| Erich Mohr | None | Other type of transaction at price $ 0.00 per share. | 03 Oct 2016 | 528 | 887 | - | - | Common Stock | |
| Jeffrey A. Bacha | Director, CEO | Other type of transaction at price $ 0.00 per share. | 03 Oct 2016 | 176 | 34,793 | - | - | Common Stock | |
| John Bell | None | Other type of transaction at price $ 0.00 per share. | 03 Oct 2016 | 282 | 34,724 | - | - | Common Stock | |
| Robert J. Toth | None | Other type of transaction at price $ 0.00 per share. | 03 Oct 2016 | 74 | 10,999 | - | - | Common Stock | |
| Lynda Cranston | None | Other type of transaction at price $ 0.00 per share. | 03 Oct 2016 | 71 | 119 | - | - | Common Stock | |
| Dennis Brown | Director, Chief Scientific Officer | Other type of transaction at price $ 0.00 per share. | 18 Jul 2016 | 115 | 759,501 | - | - | Common Stock | |
| Scott Praill | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 18 Jul 2016 | 144 | 15,144 | - | - | Common Stock | |
| Erich Mohr | None | Other type of transaction at price $ 0.00 per share. | 18 Jul 2016 | 359 | 359 | - | - | Common Stock | |
| Jeffrey A. Bacha | Director, CEO | Other type of transaction at price $ 0.00 per share. | 18 Jul 2016 | 120 | 34,617 | - | - | Common Stock | |
| John Bell | None | Other type of transaction at price $ 0.00 per share. | 18 Jul 2016 | 192 | 34,442 | - | - | Common Stock | |
| Robert J. Toth | None | Other type of transaction at price $ 0.00 per share. | 18 Jul 2016 | 50 | 10,925 | - | - | Common Stock | |
| Lynda Cranston | None | Other type of transaction at price $ 0.00 per share. | 18 Jul 2016 | 48 | 48 | - | - | Common Stock | |
| John Bell | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 22 Apr 2014 | 20,000 | 64,000 | - | - | Common Stock | |
| Dennis Brown | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2014 | 10,000 | 2,952,542 | - | - | Common Stock | |
| Scott Praill | CFO | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2014 | 10,000 | 10,000 | - | - | Common Stock | |
| William J. Garner | None | 18 Mar 2014 | 80,000 | 90,000 | - | - | Common Stock | ||
| William J. Garner | None | 18 Mar 2014 | 80,000 | 2,513,541 | - | - | Exchangeable Shares | ||
| William J. Garner | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2014 | 10,000 | 30,000 | - | - | Common Stock | |
| William J. Garner | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2014 | 25,000 | 65,000 | - | - | Common Stock | |
| William J. Garner | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2014 | 10,000 | 20,000 | - | - | Common Stock | |
| William J. Garner | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2014 | 10,000 | 10,000 | - | - | Common Stock | |
| William J. Garner | None | Sale of securities on an exchange or to another person at price $ 0.00 per share. | 18 Mar 2014 | 25,000 | 40,000 | - | - | Common Stock | |
| Jeffrey A. Bacha | Director, CEO and President, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2014 | 10,000 | 42,000 | - | - | Common Stock | |
| John Bell | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2014 | 25,000 | 44,000 | - | - | Common Stock | |
| Robert J. Toth | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 18 Mar 2014 | 25,000 | 43,500 | - | - | Common Stock | |
| Dennis Brown | Director, Chief Scientific Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 04 Mar 2014 | 5,000 | 2,942,542 | - | - | Common Stock | |
| Jeffrey A. Bacha | Director, CEO and PRESIDENT, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 21 Feb 2014 | 5,000 | 32,000 | - | - | COMMON STOCK | |
| Jeffrey A. Bacha | Director, CEO and PRESIDENT, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 13 Feb 2014 | 5,000 | 27,000 | - | - | COMMON STOCK | |
| John Bell | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 11 Feb 2014 | 9,000 | 19,000 | - | - | Common Stock | |
| Robert J. Toth | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 05 Feb 2014 | 9,000 | 18,500 | - | - | COMMON STOCK | |
| Robert J. Toth | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 31 Jan 2014 | 2,000 | 9,500 | - | - | Common Stock | |
| Robert J. Toth | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 29 Jan 2014 | 7,500 | 7,500 | - | - | COMMON STOCK | |
| William J. Garner | None | 26 Nov 2013 | 5,000 | 10,000 | - | - | Common Stock | ||
| William J. Garner | None | 26 Nov 2013 | 5,000 | 45,000 | - | - | Warrants (Right to Buy) | ||
| William J. Garner | None | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Sep 2013 | 5,000 | 5,000 | - | - | Common Stock | |
| Dennis Brown | Director, Chief Scientific Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2013 | 350,000 | 350,000 | - | - | Options (Right to Buy) | |
| Scott Praill | CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2013 | 350,000 | 350,000 | - | - | Options (Right to Buy) | |
| William J. Garner | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2013 | 120,000 | 120,000 | - | - | Options (Right to Buy) | |
| Jeffrey A. Bacha | Director, CEO and President, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2013 | 350,000 | 350,000 | - | - | Options (Right to Buy) | |
| John Bell | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2013 | 120,000 | 120,000 | - | - | Options (Right to Buy) | |
| John Bell | None | 16 Aug 2013 | 10,000 | 90,000 | - | - | Warrants (Right to Buy) | ||
| John Bell | None | 16 Aug 2013 | 10,000 | 10,000 | - | - | Common Stock | ||
| Jeffrey A. Bacha | Director, CEO and President, Ten Percent Owner | 05 Aug 2013 | 22,000 | 198,000 | - | - | Warrants (Right to Buy) | ||
| Jeffrey A. Bacha | Director, CEO and President, Ten Percent Owner | 05 Aug 2013 | 22,000 | 22,000 | - | - | Common Stock | ||
| Dennis Brown | Director, Chief Scientific Officer, Ten Percent Owner | 02 Aug 2013 | 10,000 | 90,000 | - | - | Warrants (Right to Buy) | ||
| Dennis Brown | Director, Chief Scientific Officer, Ten Percent Owner | 02 Aug 2013 | 24,000 | 216,000 | - | - | Warrants (Right to Buy) | ||
| Dennis Brown | Director, Chief Scientific Officer, Ten Percent Owner | 02 Aug 2013 | 34,000 | 2,937,542 | - | - | Common Stock |